E Fund Management Co., Ltd. Point Biopharma Global Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.93 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$6.67 - $9.71 $6,263 - $9,117
939 Added 8.92%
11,463 $76,000
Q2 2023

Aug 11, 2023
BUY
$6.86 - $10.86 $72,194 - $114,290
10,524 New
10,524 $95,000
Q4 2022

Feb 14, 2023
BUY
$5.72 - $9.78 $30,418 - $52,010
5,318 Added 52.08%
15,530 $113,000
Q3 2022

Nov 14, 2022
BUY
$7.24 - $10.31 $73,934 - $105,285
10,212 New
10,212 $79,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email